Deep Track Capital’s Latigo Biotherapeutics LTGO Stock Holding History
Bought
Maintained
Sold
Other funds holding LTGO
Deep Track Capital's LTGO Position: Q3 2026 in Review
Deep Track Capital opened a new position in Latigo Biotherapeutics (LTGO) in Q3 2026: 4,408,322 shares worth $73.6M. The stake represents 1.2% of the portfolio and ranks #30 among its holdings.
58 funds tracked by Wall St. Rank hold LTGO as of Q3 2026.
- Deep Track Capital held 4,408,322 shares of Latigo Biotherapeutics worth $73.6M as of Q3 2026.
- Latigo Biotherapeutics was a new Deep Track Capital position in Q3 2026.
- Latigo Biotherapeutics made up 1.2% of Deep Track Capital's portfolio in Q3 2026, its #30 holding.
- 58 funds tracked by Wall St. Rank held Latigo Biotherapeutics as of Q3 2026.
Based on Deep Track Capital's 13F filing for Q3 2026, filed 16 Nov 2026.